Chief Executive Officer of French artificial heart manufacturer Carmat, Stephane Piat, poses holding an artificial heart during an interview with Reuters in Velizy, near Paris
French artificial heartmaker Carmat (ALCAR.PA) announced on Tuesday that it had carried out the first implant of its Aeson artificial heart in a woman.
The company said the procedure had been performed at the UofL Health - Jewish Hospital by University of Louisville physicians in the United States.
"This third implant in the U.S. was a landmark event not only because it allowed us to finalize the enrollment of the first cohort of patients of the EFS (early feasibility study), but very importantly because it is the first time ever that our device has helped a woman suffering from heart failure," Carmat CEO Stephane Piat said in a statement.
Reporting by Matthieu Protard; Editing by Sudip Kar-Gupta
Important Update: MetroExpress Service ONLY Available via Karwa Taxi App from June 24
WhatsApp lets users hide profile photo, last seen from specific people
Box Office: Pixar's 'Lightyear' Underwhelms With $51 Million Debut as 'Jurassic World' Stays No. 1
Qatar ranks number one most peaceful country in Arab World